Skip to main content
Emily Ko, MD, Obstetrics & Gynecology, Philadelphia, PA

Emily M Ko MD

Gynecologic Oncology


Professor, Obstetrics & Gynecology, Perelman School of Medicine

Join to view full profile
  • 800 Walnut Street10th FloorPhiladelphia, PA 19107

  • Phone+1 215-829-2345

Dr. Ko is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Emily Ko is board certified in Gynecologic Oncology and Obstetrics and Gynecology, who currently serves as Professor of Gynecologic Oncology at Pennsylvania Hospital and Hospital of the University of Pennsylvania. She serves as Medical Director of the Pennsylvania Hospital Abramson Cancer Center. Located in Philadelphia, Dr. Ko has a subspecialty in Gynecologic Oncology. Her education includes a Residency at Harvard Medical School Brigham and Women's Hospital and Massachusetts General Hospital Combined OBGYN Residency, a medical degree from University of Massachusetts Medical School, a Fellowship in Gynecologic Oncology at University of North Carolina Hospitals, and an MSCR in Epidemiology from University of North Carolina Gillings School of Public Health. Dr. Ko's expertise spans surgical and medical management of all gynecologic cancers and pre-cancers as well as complex pelvic surgery. She is a prominent scholar in populations sciences and health services research as well as clinical trials with numerous publications in prestigious journals. She has conducted significant clinical trials and is well-respected in her field, as evidenced by her leadership roles in professional organizations and several honors and awards.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Gynecologic Oncology, 2012
  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalResidency, Obstetrics and Gynecology, 2005 - 2009
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 2005
  • University of North Carolina Gillings School of Public Health
    University of North Carolina Gillings School of Public HealthMSCR, Epidemiology

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2017 - 2027
  • PA State Medical License
    PA State Medical License 2013 - 2026
  • NC State Medical License
    NC State Medical License 2009 - 2013
  • Obstetrics & Gynecology
    American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • Gynecologic Oncology
    American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Survival Following Minimally Invasive Radical Hysterectomy for Patients with Cervical Carcinoma and Tumor Size Less Than or Equal to 2 Cm  
    Benjamin Albright, Emily M Ko, American Journal of Obstetrics and Gynecology
  • Trends in the Surgical Management of Malignant Ovarian Germ-Cell Tumors  
    Spyridon A Mastroyannis, Emily M Ko, Gynecologic Oncology

Press Mentions

  • Anti-Inflammatory Agents May Have Role in COVID-19 Pneumonia
    Anti-Inflammatory Agents May Have Role in COVID-19 PneumoniaOctober 25th, 2022
  • Blood Test Shows Promise in More Accurate Detection of Ovarian Cancer
    Blood Test Shows Promise in More Accurate Detection of Ovarian CancerJune 15th, 2022
  • Gynecologic Cancer Survival Impacted by Race
    Gynecologic Cancer Survival Impacted by RaceMarch 15th, 2022

Professional Memberships

Other Languages

  • Chinese (Mandarin), Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: